Correlation Between Scpharmaceuticals and BioAffinity Technologies,
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and bioAffinity Technologies,, you can compare the effects of market volatilities on Scpharmaceuticals and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and BioAffinity Technologies,.
Diversification Opportunities for Scpharmaceuticals and BioAffinity Technologies,
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Scpharmaceuticals and BioAffinity is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and BioAffinity Technologies, go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and BioAffinity Technologies,
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the BioAffinity Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.89 times less risky than BioAffinity Technologies,. The stock trades about -0.05 of its potential returns per unit of risk. The bioAffinity Technologies, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 147.00 in bioAffinity Technologies, on August 25, 2024 and sell it today you would lose (25.00) from holding bioAffinity Technologies, or give up 17.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. bioAffinity Technologies,
Performance |
| Timeline |
| Scpharmaceuticals |
| bioAffinity Technologies, |
Scpharmaceuticals and BioAffinity Technologies, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and BioAffinity Technologies,
The main advantage of trading using opposite Scpharmaceuticals and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| BioAffinity Technologies, vs. Eliem Therapeutics | BioAffinity Technologies, vs. HCW Biologics | BioAffinity Technologies, vs. Scpharmaceuticals | BioAffinity Technologies, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |